Form 4 for NVAX NOVAVAX INC
Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-21 · accession 0001593968-24-000910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-25 | 2024-06-21 | NVAX | YOUNG JAMES F | Dir | S - Sale | $14.09 | -7,500 | 61.8K | -11% | -$105.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | S | D | 7,500 | $14.09 | 61,760 | D | — | — |